Zn[(l)proline]: A powerful catalyst for the very fast synthesis of quinoxaline derivatives at room temperature

Catalysis Communications

Volumn 8, Issue 9, 2007, Pages 1341-1344

  Heravi, Majid M ^a   Tehrani, Maryam H ^a   Bakhtiari, Khadijeh ^a   Oskooie, Hossein A ^a  

^a ALZAHRA UNIVERSITY   (Iran)

Author keywords

1,2 Diketones; o Phenylenediamines; Quinoxaline; Reusable catalyst; Zn (l)proline

Indexed keywords

DICARBONYL COMPOUNDS; QUINOXALINE DERIVATIVES; REUSABLE CATALYSTS;

AMINES; CONDENSATION; SYNTHESIS (CHEMICAL); THERMAL EFFECTS;

CATALYSTS;

EID: 34447503639     PISSN: 15667367     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.catcom.2006.11.026     Document Type: Article

References (28)

1. Sakata G., and Makino K. Heterocycles 27 (1988) 2481
2. T.S. Osdene, US Patent 3, 185, 688, 1965. Chem. Abstr. 46 (1965) 3191.
3. Waisser K., Odlerova Z., Beckert R., and Mayer R. Pharmazie 44 (1989) 234
4. Seitz L.E., Suling W.J., and Reynolds R.C. J. Med. Chem. 45 (2002) 5604
5. Babichev F.S., Grinevich A.I., Volovenko Yu.M., Litvinenko S.V., Roshchupkina E.V., and D'yachenko V.Yu. Farm. Zh. (1989) 53
6. Badran M.M., Botros S., El-Gendy A.A., Abdou N.A., El-Assi H., and Salem A. Bull. Pharm. Sci. 24 (2001) 135
7. Hazeldine S.T., Polin L., Kushner J., Paluch J., White K., Edelstein M., Palomino E., Corbett T.H., and Horwitz J.P. J. Med. Chem. 44 (2001) 1758
8. Hazeldine S.T., Polin L., Kushner J., White K., Bouregeois N.M., Crantz B., Palomino E., Corbett T.H., and Horwitz J.P. J. Med. Chem. 45 (2002) 3130
9. E.D. Brock, D.M. Lewis, T.I. Yousaf, H.H. Harper, The Procter & Gamble Company, USA WO, 1999 9951688.
10. Gazit A., App H., McMahon G., Chen J., Levitzki A., and Bohmer F.D. J. Med. Chem. 39 (1996) 2170
11. Sehlstedt U., Aich P., Bergman J., Vallberg H., Norden B., and Graslund A. J. Mol. Biol. 278 (1998) 31
12. Dailey S., Feast J.W., Peace R.J., Till I.C., Sage S., and Wood E.L. J. Mater. Chem. 11 (2001) 2238
13. O'Brien D., Weaver M.S., Lidzey D.G., and Bradley D.D.C. Appl. Phys. Lett. 69 (1996) 881
14. Dell A., William D.H., Morris H.R., Smith G.A., Feeney J., and Roberts G.C.K. J. Am. Chem. Soc. 97 (1975) 2497
15. Bailly C., Echepare S., Gago F., and Waring M. J. Anti-Cancer Drug Des. 15 (1999) 291
16. Sato S., Shiratori O., and Katagiri K. J. Antibiot. 20 (1967) 270 (and references cited therein.)
17. Reviews: A.E. Porter, in: A.R Katritzky, C.W. Rees, (Eds.), Comprehensive Heterocyclic Chemistry. R Katritzky, C.W. Rees (Eds.) vol. 3, 1984, p. 157 (part 2B).
18. Sato N. In: Katritzky A.R., Rees C.W., and Scriven E.F.V. (Eds). Comprehensive Heterocyclic Chemistry II vol. 6 (1996), Pergamon, Oxford 233
19. Cheeseman G.W.H., and Werstiuk E.S.G. Adv. Heterocycl. Chem. 22 (1978) 367
20. Woo G.H.C., Snyder J.K., and Wan Z.K. Prog. Heterocycl. Chem. 14 (2002) 279
21. Zemin Wu., and Ede N.J. Tetrahedron Lett. 42 (2001) 8115
22. Brown D.J. Quinoxalines: Supplement II. In: Taylor E.C.P., and Wipf (Eds). The Chemistry of Heterocyclic Compounds (2004), John Wiley & Sons, New Jersey
23. List B., Lerner R.A., and Barbas III C.F. J. Am. Chem. Soc. 122 (2000) 2395
24. Notz W., and List B. J. Am. Chem. Soc. 122 (2000) 7386
25. Sakthivel K., Notz W., Bui T., and Barbas III C.F. J. Am. Chem. Soc. 123 (2001) 5260
26. Sivamurugan V., Deepa K., Palanichamy M., and Murugesan V. Synth. Commun. 34 (2004) 3833
27. M.M. Heravi, Sh. Taheri, Kh. Bakhtiari, H.A. Oskooie, Catal. Commun., in Press.
28. Darbre T., and Machuqueiro M. Chem. Commun. (2003) 1090